Fig. 4: In vivo adenine base editing of the PCSK9 locus in the liver of macaques. | Nature Biotechnology

Fig. 4: In vivo adenine base editing of the PCSK9 locus in the liver of macaques.

From: In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels

Fig. 4: In vivo adenine base editing of the PCSK9 locus in the liver of macaques.The alternative text for this image may have been generated using AI.

a, Schematic outline of the experiments. Levels of ALT (b), TNF-α (b) and IP-10 (c). Day 15 is before re-dosing; Day 15, 6 h is 6 h after re-dosing. e, Histopathology of liver samples from untreated, 1.5 mg kg−1 single-dosed and 1.5 mg kg−1 re-dosed animals. Three different liver lobes of all animals of the high-dose groups were examined by a trained pathologist. Only very mild lobular mixed inflammatory cell infiltration was observed (white arrowhead). Black arrowheads indicate portal tracts. H&E; scale bar, 200 μm. f, Percent editing in treatment groups (six liver biopsies per animal analyzed). g, PCSK9 levels. Serum from two time points before (Day –12 and Day −1) and after (Day 22 and Day 29) treatment was analyzed. *P = 0.020 (1.5 mg kg−1); *P = 0.027 (1.5 mg kg−1 re-dose). h, LDL levels. Serum from two time points before (Day –12 and Day –1) and after (Day 22 and Day 29) treatment was analyzed. NS = 0.091; **P = 0.008. i, Background-subtracted absorbance (A450 – A540) representing the relative amount of anti-Cas9-specific IgG antibodies. 5% BSA coating was used to determine background levels. Means were compared to Day −1. *P = 0.0095. j, Background-subtracted absorbance (A450 – A540) representing the relative amount of anti-TadA-specific IgG antibodies. Means were compared to Day −1. *P = 0.0336, **P = 0.0026. k, Editing rates in DNA isolated from other tissues than the liver. l, sgRNA-dependent off-target sites of sgRNA_hP01 in the human genome identified using CIRCLE-seq. The top eight hits with orthologous sites in M. fasciularis were analyzed by NGS in vitro (HepG2 cells transfected with plasmids encoding ABEmax and sgRNA_hP01) and in vivo (3 mg kg−1 single-dosed and re-dosed). Values represent the highest A-to-G conversion frequency within the protospacer. n = 3 biological replicates per treatment. Control: DNA isolated from untreated HepG2 cells and macaque blood cells before treatment. MM, mismatches between the human and M. fasciularis genome. Values represent mean ± s.d. of n = 3 animals. Means were compared using one-tailed paired t-test.

Back to article page